Markers of Antioxidant Defense in Patients with Type 2 Diabetes von Solnica, B., Dumnicka, Paulina, Grudzień, U., Pawlica-Gosiewska, D., Fedak, Danuta, Naskalski, J. W., Gawlik, K., Malecki, Maciej T.

Volltext

Negative-pressure wound therapy for management of chronic neuropathic noninfected diabetic foot ulcerations – short-term efficacy and long-term outcomes von Borys, S, Hohendorff, J, Koblik, T, Witek, P, Ludwig-Slomczynska, AH, Frankfurter, C, Kiec-Wilk, B, Malecki, MT

Volltext

Impact of FTO genotypes on BMI and weight in polycystic ovary syndrome: a systematic review and meta-analysis von Wojciechowski, P., Lipowska, A., Rys, P., Ewens, K. G., Franks, S., Tan, S., Lerchbaum, E., Vcelak, J., Attaoua, R., Straczkowski, M., Azziz, R., Barber, T. M., Hinney, A., Obermayer-Pietsch, B., Lukasova, P., Bendlova, B., Grigorescu, F., Kowalska, I., Goodarzi, M. O., Strauss, J. F., McCarthy, M. I., Malecki, M. T.

Volltext

1,5-Anhydroglucitol as a marker of maternal glycaemic control and predictor of neonatal birthweight in pregnancies complicated by type 1 diabetes mellitus von Nowak, N., Skupien, J., Cyganek, K., Matejko, B., Malecki, M. T.

Volltext

Induced pluripotent stem cells as a model for diabetes investigation von Stepniewski, J., Kachamakova-Trojanowska, N., Ogrocki, D., Szopa, M., Matlok, M., Beilharz, M., Dyduch, G., Malecki, M. T., Jozkowicz, A., Dulak, J.

Volltext

Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis von Schernthaner, G, Barnett, A. H, Betteridge, D. J, Carmena, R, Ceriello, A, Charbonnel, B, Hanefeld, M, Lehmann, R, Malecki, M. T, Nesto, R, Pirags, V, Scheen, A, Seufert, J, Sjohölm, A, Tsatsoulis, A, DeFronzo, R

Volltext

A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes von Thanabalasingham, G., Shah, N., Vaxillaire, M., Hansen, T., Tuomi, T., Gašperíková, D., Szopa, M., Tjora, E., James, T. J., Kokko, P., Loiseleur, F., Andersson, E., Gaget, S., Isomaa, B., Nowak, N., Raeder, H., Stanik, J., Njolstad, P. R., Malecki, M. T., Klimes, I., Groop, L., Pedersen, O., Froguel, P., McCarthy, M. I., Gloyn, A. L., Owen, K. R.

Volltext

Referral rates for diagnostic testing support an incidence of permanent neonatal diabetes in three European countries of at least 1 in 260,000 live births von Slingerland, A. S, Shields, B. M, Flanagan, S. E, Bruining, G. J, Noordam, K, Gach, A, Mlynarski, W, Malecki, M. T, Hattersley, A. T, Ellard, S

Volltext

A single dose of dapagliflozin, an SGLT-2 inhibitor, induces higher glycosuria in GCK- and HNF1A-MODY than in type 2 diabetes mellitus von Hohendorff, J., Szopa, M., Skupien, J., Kapusta, M., Zapala, B., Platek, T., Mrozinska, S., Parpan, T., Glodzik, W., Ludwig-Galezowska, A., Kiec-Wilk, B., Klupa, T., Malecki, M. T.

Volltext

search for undiagnosed MODY patients: what is the next step von Malecki, M. T

Volltext

Efficacy and safety comparison of rapid-acting insulin aspart and regular human insulin in the treatment of type 1 and type 2 diabetes mellitus: A systematic review von Rys, P, Pankiewicz, O, Łach, K, Kwaskowski, A, Skrzekowska-Baran, I, Malecki, M.T

Volltext

Apolipoprotein M can discriminate HNF1A-MODY from Type 1 diabetes von Mughal, S. A., Park, R., Nowak, N., Gloyn, A. L., Karpe, F., Matile, H., Malecki, M. T., McCarthy, M. I., Stoffel, M., Owen, K. R.

Volltext

Osteoprotegerin gene polymorphism in diabetic Charcot neuroarthropathy von Korzon-Burakowska, A., Jakóbkiewicz-Banecka, J., Fiedosiuk, A., Petrova, N., Koblik, T., Gabig-Cimińska, M., Edmonds, M., Małecki, M. T., Węgrzyn, G.

Volltext

Paraoxonase gene polymorphisms and sporadic ALS von SLOWIK, A, TOMIK, B, WOLKOW, P. P, PARTYKA, D, TURAJ, W, MALECKI, M. T, PERA, J, DZIEDZIC, T, SZCZUDLIK, A, FIGLEWICZ, D. A

Volltext

DNA methylation analysis of negative pressure therapy effect in diabetic foot ulcers von Ludwig-Slomczynska, A H, Borys, S, Seweryn, M T, Hohendorff, J, Kapusta, P, Kiec-Wilk, B, Pitera, E, Wolkow, P P, Malecki, M T

Volltext

Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus von Krolewski, Andrzej S, Malecki, Maciej T, Jhala, Ulupi S, Antonellis, Anthony, Fields, Liz, Doria, Alessandro, Orban, Tihamer, Saad, Mohammed, Warram, James H, Montminy, Marc

Volltext

Molecular background and clinical characteristics of HNF1A MODY in a Polish population von Skupien, J, Gorczynska-Kosiorz, S, Klupa, T, Cyganek, K, Wanic, K, Borowiec, M, Sieradzki, J, Malecki, M.-T

Volltext

Altered fibrin-clot properties are associated with retinopathy in type 2 diabetes mellitus von Walus-Miarka, M, Wolkow, P, Cyganek, K, Mirkiewicz-Sieradzka, B, Malecki, M.T, Undas, A

Volltext

Carotid Plaques Correlates in Patients With Familial Hypercholesterolemia von Waluś-Miarka, Małgorzata, Czarnecka, D., Wojciechowska, W., Kloch-Badełek, M., Kapusta, M., Sanak, M., Wójcik, M., Małecki, M. T., Starzyk, J., Idzior-Waluś, B.

Volltext

The FTO gene modifies weight, fat mass and insulin sensitivity in women with polycystic ovary syndrome, where its role may be larger than in other phenotypes von Kowalska, I, Malecki, M.T, Straczkowski, M, Skupien, J, Karczewska-Kupczewska, M, Nikolajuk, A, Szopa, M, Adamska, A, Wawrusiewicz-Kurylonek, N, Wołczynski, S, Sieradzki, J, Gorska, M

Volltext